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Assessment of Propranolol efficacy on pediatric haemangioma 
Abstract  
Introduction  
Hemangiomas are the most common vascular tumor in infancy. Systemic cortons are the first 
choice of treatment although they have many side effects. Recent studies show Propranolol 
efficacy on hemangiomas treatment. It has rapid effect and few side effects. These reasons 
make us to review its effect. 
 
Materials and methods  
This interventional study was done on 20 children refer to Bu-Ali hospital. Treatment 
indications were multiple hemangiomas, organ malfunction and enlarging hemangioma. 
Treatment on those was started by 1mg/kg/day and increased to 3 mg/kg/day and continued 
for 6 month. After treatment completion 6 month follow up was done. 
 
Results  
Patients mean age was 23.15 ± 11.24 month. 65% of them were female and 35% was male. 
Mean size of lesion was 4.85 ± 3.26 Cm. 70% patients had acceptable respond (more than 
50% decrease in size) and 30% had partial respond (less than 50%). This effect is similar to 
corton effect (about 84%) but with less side effects. In this study there is no significant 
relation between size of lesion, age, sex and regression.  
 
Conclusion 
This study shows that Propranolol has acceptable effect on hemangiomas regression and 
could be suggested as first choice of hemangimas treatment. 
 
Key words: Hemangioma, Propranolol, Pediatric clinic  
 
 
 
 
 
